{"id":"W1607152800","doi":"10.3747/co.v13i1.91","title":"Adjuvant Trastuzumab: Progress, Controversies, and the Steps Ahead","year":2006,"lang":"en","type":"article","venue":"Current Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Trastuzumab; Medicine; Adjuvant; Breast cancer; Oncology; Clinical trial; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02003734,0.0007959165,0.001529273,0.001075258,0.001118885,0.004491123,0.001493675,0.005328631,0.002991827],"category_scores_gemma":[0.02304295,0.0002975451,0.0007339022,0.001719648,0.003782256,0.00906517,0.002150487,0.0114693,0.001122332],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003257536,"about_ca_system_score_gemma":0.006077188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002725597,"about_ca_topic_score_gemma":0.006445833,"domain_scores_codex":[0.9969712,0.001218937,0.0005292346,0.0002087105,0.0007666408,0.000305163],"domain_scores_gemma":[0.9810193,0.01300035,0.001071393,0.000431935,0.003052958,0.001424026],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001059816,0.0001945439,0.001507175,0.002958641,0.0001352744,0.000344991,0.0003652968,0.0004671826,0.0008778843,0.03576513,0.1257063,0.8306178],"study_design_scores_gemma":[0.0002693826,0.0005998059,0.002134835,0.005875437,0.0002766111,0.0008119957,0.00145608,0.0004201965,0.0009764277,0.07884779,0.9082442,0.00008732357],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001042106,0.6820984,0.0005810988,0.3116855,0.003079753,0.00001110326,0.00003788123,0.00002308102,0.001441009],"genre_scores_gemma":[0.01921792,0.8644606,0.002498806,0.09427636,0.01759258,0.00003730301,0.00007893357,0.00003725224,0.001800279],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02003734,"threshold_uncertainty_score":0.1059688,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09057353432679374,"score_gpt":0.4466241473911161,"score_spread":0.3560506130643223,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}